Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Multicare Pharmaceuticals, the Philippines subsidiary of Lupin, is set to market and distribute Sanofi-Aventis' central nervous system (CNS) global brands Solian (Amisulpride) and Stilnox (Zolpidem Hemitartrate) in the Philippines.
Subscribe to our email newsletter
Solian is indicated as a treatment for acute and chronic schizophrenia characterized by both negative and positive symptoms, while Stilnox is used for the treatment of insomnia and sleep disorders.
Under the contract, the products will be marketed by Multicare’s CNS Business Unit.
Multicare president Romey Sy said Multicare has four key strategic business units focused on Women’s Health, Pediatrics, Respiratory, GI, Diabetes Care & CNS.